Body Composition Sub-study of the D2EFT Trial

NCT03675815 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

155

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Darunavir (DRV) 800 milligram (MG) Oral Tablet
DRUG: Ritonavir 100 MG Oral Tablet
DRUG: N(t)RTIs
DRUG: Dolutegravir 50 MG Oral Tablet
DRUG: TDF 300 MG Oral Tablet
DRUG: 3TC 300 MG Oral Tablet
DRUG: FTC 200 MG Oral Cap

Sponsor

Kirby Institute